Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Drug Alcohol Depend. 2018 Nov 28;194:453–459. doi: 10.1016/j.drugalcdep.2018.11.010

Table 3.

Comparisons of mean percent correct on the 5-item Hepatitis C Virus Injection-risk Knowledge Scale (HCV-IRKS)

 
Number Mean percent correct Degrees of freedom t test statistic p-value
Hepatitis C antibody positive result on OraQuick test 104 89.2 239 −6.33 <0.0001
Hepatitis C antibody negative result on OraQuick test 425 71.7
Previously tested for HCV 366 83.2 257 −8.30 <0.0001
Not previously tested for HCV 166 56.5
Positive result on previous HCV test (self-report) 75 90.7 166 −3.25 0.001
Negative result on previous HCV test (self-report) 274 80.9
Lifetime drug injection 343 87.2 284 −12.3 <0.0001
No lifetime drug injection 187 51.4
Past 30 day injection (among ever injectors) 301 87.8 346 −1.13 0.2586
No past 30 day injection (among ever injectors) 44 83.4
Very/somewhat concerned about getting HCV 300 75.5 448 −2.47 0.0138
Not at all concerned about getting HCV 150 67.1
Very often/often/sometimes talked about HCV with drug-using friends 183 86.9 499 −6.91 <0.0001
Rarely/never talked about HCV with drug-using friends 345 68.8
Learned about HCV from primary doctor or in drug treatment 375 78.2 252 −3.40 0.0008
Never learned about HCV from primary doctor or in drug treatment 157 66.8
Learned about HCV from syringe exchange, harm reduction, other service provider 245 84.4 527 −6.41 <0.0001
Never learned about HCV from syringe exchange, harm reduction, other service provider 278 66.7